Oral Hypoglycemic Agents,Oral

DRUG2 trials

Sponsors

Scotmann Pharmaceuticals, Dr Mudassar Saeed Pansota

Conditions

Diabetes MellitusGestational Diabetes Mellitus (GDM)

Phase 3

Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus

Scotmann PharmaceuticalsDiabetes Mellitus

Start: 2022-08-31End: 2023-06-30Target: 340Updated: 2022-06-14

Unknown Phase

Insulin Versus Oral Hypoglycemic Agents in Gestational Diabetes Mellitus

CompletedNCT07582471

Dr Mudassar Saeed PansotaGestational Diabetes Mellitus (GDM)

Start: 2025-10-08End: 2026-04-07Updated: 2026-05-14